Featured

[Special Report] Trademark filing and litigation trends 2024: Insights and opportunities

Robert Reading

Director, Corporate Strategy, Content at Clarivate

Biopharma
What a string of semaglutide biosimilars could mean for Mainland China
Academia and Government
Introducing the Clarivate Academic AI Platform
Life Sciences and Healthcare
September 20, 2019
Life Sciences and Healthcare
September 18, 2019
Intellectual Property
September 2, 2019
Academia and Government
September 2, 2019